Loading...

Antitrust audits

The experts of our antitrust practice have conducted a lot of antitrust audits in relation to the activities of pharmaceutical companies, accumulating thus a wealth of knowledge concerning the specifics of this industry’s business in the Russian market. As a result, our lawyers successfully implement their knowledge of the main antitrust risks and means to prevent them when supporting a range of audits conducted by the Russian Federal Antimonopoly Service in relation to pharmaceutical companies, and, subsequently, during the regulator’s decisions being contested in courts. 

Back to the list

27.10.2025
Sergey Sosnovsky Returns to Pepeliaev Group’s Team
Read more
24.10.2025
Pepeliaev Group and Business Russia’s Industrial Closed-End Mutual Investment Funds Subcommittee Have Entered into a Strategic Partnership
Read more
20.10.2025
A Partner from Pepeliaev Group is Heading Up the New Expert Centre of Business Russia
Read more